Home › Urothelial (Transitional Cell) Carcinoma › North Carolina › Durham

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Durham, NC

Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #12, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Nagre-recruitPhase 2

UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Nagre-recruitObservasyonal na pag-aaral

The University of North Carolina Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Nagre-recruitPhase 1/2

Duke University Medical Center (location of scans), Durham
Duke University Medical Center - Duke University Hospital (location of scans), Durham
Duke University Medical Center, Durham
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Nagre-recruitPhase 2/3

Research Site, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07129993

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Nagre-recruitPhase 2

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Nagre-recruitPhase 1

University of North Carolina, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.